glp-1 and hypertension Agonists Blood Pressure: A Review of the Evidence | Current Reports GLP-1 medications are not just

Eating well does not have to be perfect

Our results indicate a vicious cycle of decreased dopamine releaseDRD2 signaling deficiencydecreased GSH synthesisoxidative stressdopaminergic neuron death in the progression of PD

This is a significant development because OSA is extraordinarily common, underdiagnosed, and carries real cardiovascular risk through mechanisms including intermittent hypoxia, sympathetic nervous system activation, and systemic inflammation

You are finally seeing the scale move thanks to medications like Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro/Zepbound)

From a bench perspective this is the feature that makes the molecule amphiphilic: it has a distinctly lipophilic tail attached to a polar peptide, and that combination is what drives its tendency to adsorb to plastic and glass surfaces and to behave unpredictably in dilute aqueous solution

While Eli Lilly has traditionally invested more in R&D, its recent surge in buybacks and dividends signals a growing focus on investor returns